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AbstrACt
Objectives Breast cancer is associated with overweight 
and obesity after menopause. However, clothing size as 
a proxy of adiposity in predicting postmenopausal breast 
cancer is not widely studied. We aimed to explore the 
relationships between postmenopausal breast cancer 
risk with adipose indicators (including clothing sizes) and 
weight change over adulthood.
Design Prospective cohort study.
setting England, Wales and Scotland.
Participants 17 781 postmenopausal women from the UK 
Women’s Cohort Study.
Primary outcome measure Incident cases of malignant 
breast cancers (International Classification of Diseases 
(ICD) 9 code 174 and ICD 10 code C50).
results From 282 277 person-years follow-up, there 
were 946 incident breast cancer cases with an incidence 
rate of 3.35 per 1000 women. Body mass index (HR: 
1.04; 95% CI: 1.02 to 1.07), blouse size (HR: 1.10; 1.03 to 
1.18), waist circumference (HR: 1.07; 1.01 to 1.14) and 
skirt size (HR: 1.14;1.06 to 1.22) had positive associations 
with postmenopausal breast cancer after adjustment for 
potential confounders. Increased weight over adulthood 
(HR: 1.02; 1.01 to 1.03) was also associated with 
increased risk for postmenopausal breast cancer.
Conclusions Blouse and skirt sizes can be used as 
adipose indicators in predicting postmenopausal breast 
cancer. Maintaining healthy body weight over adulthood is 
an effective measure in the prevention of postmenopausal 
breast cancer.
IntrODuCtIOn
Breast cancer is the most common cancer 
among women worldwide, accounting for 
25% of new cases.1 In the UK, it is also the 
most common cancer among women with 
around 54 800 cases diagnosed in 2014.2 The 
prevalence of obesity in the UK has increased 
from 15% in 1993 to 27% in 2015, and 57% 
of the women were overweight or obese.3 
Obesity is associated with increased risks of 
chronic diseases and certain cancers.4 5 There 
is strong evidence that obesity and weight 
gain over adult life are associated with 
increased risk of postmenopausal breast 
cancer.6 7 Maintaining healthy weight is a key 
recommendation to prevent postmenopausal 
breast cancer.6 
To date, many adipose indicators namely 
weight, body mass index (BMI), waist circum-
ference, waist to hip ratio are used in research 
and health education programmes. BMI is 
an established indicator for general obesity, 
while central obesity is commonly measured 
using waist circumference. Among postmeno-
pausal women, higher BMI and larger waist 
circumference during adulthood, and weight 
gain over adulthood are associated with 
increased breast cancer risk.6
Clothing sizes are objective, easy to recall 
and less likely to be misreported. From a 
public health perspective, clothing sizes may 
be useful when anthropometric measure-
ments are not available or challenging in their 
measurements due to extreme obesity. Skirt 
or trouser size8–10 have been suggested to be 
used as proxy for central obesity. Skirt size 
appears to predict cancer risk independently 
of BMI.10 Change in skirt size was also found 
to be predictive of postmenopausal breast 
cancer.11 However, blouse size has not been 
strengths and limitations of this study
 ► This study may be the first to report the use of both 
blouse and skirt sizes as measures of body size.
 ► The large study sample with long follow-up dura-
tion and linkage of participants’ ID with the National 
Statistics National Health Service central register 
provides accurate information on breast cancer 
diagnosis.
 ► All adipose indicators, blouse and skirt sizes, were 
self-reported.
 ► We were unable to evaluate in more detail the effect 
of weight gain at different ages.
 ► Breast tumour characteristics were not available, 
and we could not explore whether our findings may 
differ by breast cancer subtypes.
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explored as a proxy for general obesity in predicting 
postmenopausal breast cancer. In view of the limited 
evidence of using clothing size as an adiposity indicator 
in predicting postmenopausal breast cancer risk, and the 
ease of self-reporting of these measures, we have used data 
from the UK Women’s Cohort Study (UKWCS) to explore 
the relationships between postmenopausal breast cancer 
risk with various adipose indicators (including skirt and 
blouse sizes); as well as weight change over adulthood.
MAterIAls AnD MethODs
study design and population
The recruitment of participants and characteristics of 
the UKWCS have been described in detail previously.12 
In brief, a total of 35 792 women were recruited between 
1995 and 1998 via a postal questionnaire. They were 
aged 35–69 years at baseline and were living in England, 
Wales and Scotland. In total, 17 781 women were post-
menopausal, and 15 951 women were premenopausal at 
baseline. Postmenopausal women were those who had 
not had a natural menstrual period in the last 12 months, 
or were older than 50 years and currently on hormone 
replacement therapy (HRT), or with a previous hyster-
ectomy and HRT. Where these data were missing, if the 
woman was aged more than 50 years she was also counted 
as menopausal. Only postmenopausal women were 
included in the current analyses.
ethics clearance
A total of 174 local research ethics committees were 
contacted and permission to carry out the baseline UKWCS 
study was obtained.13 Participants had consented to the 
use of information gathered at baseline, future phases 
and cancer registries for research purposes provided that 
confidentiality was maintained. The National Research 
Ethics Committee for Yorkshire and the Humber, Leeds 
East have now taken on responsibility for the on-going 
cohort.14
Patient and public involvement
The participants were not involved in the development of 
the research question and outcome measures. They were 
also not involved in the design and conduct of the study. 
The results are not disseminated to the participants apart 
from the UKWCS website.
Case definition and ascertainment
All women were flagged for death and cancer registra-
tion on the office of National Statistics National Health 
Service central register. Causes of death and cancer diag-
nosis were coded in the International Classification of 
Diseases (ICD) 9 and 10. All malignant breast cancers 
(ICD 9 code 174 and ICD 10 code C50) registered after 
the participants returned their questionnaires were taken 
as incident cases. Prevalent cancers identified from the 
questionnaires and incident cases identified within 1 year 
from the date of questionnaire returned were excluded 
to rule out reverse causation since undiagnosed breast 
cancer may influence weight.
Assessment of adipose indicators
Anthropometric measures such as weight, height, waist 
and hip circumference at enrolment; and weight at age 
20 years were self-recorded. BMI was categorised into 
groups of underweight, normal weight, overweight and 
obese according to the WHO criteria.15 Weight change 
over adulthood was computed by weight at enrol-
ment minus weight at 20 years old. Weight change was 
further categorised into stable weight (±2 kg), weight loss 
(2–4.9 kg and >5 kg) and weight gain (2–9.9 kg, 10–19.9 kg 
and >20 kg). Skirt size and blouse size at enrolment were 
also reported. The clothing sizes ranged from 6 to 26 with 
the increase in units of 2.
Other confounding factors
Socioeconomic characteristics, dietary pattern (meat 
eaters, fish eaters or vegetarian), lifestyle (smoking, 
alcohol consumption, physical activity, etc), reproductive 
history, information on past health experience, sibling 
and parental health were reported at baseline.
statistical analysis
The follow-up (person-years) for each participant was 
counted from the beginning of the study until the date of 
breast cancer diagnosis or the censor date (1 April 2014), 
whichever occurred first. The median follow-up was 16.9 
years. The relationships between adipose indicators and 
weight change; and postmenopausal breast cancer were 
explored using Cox’s proportional hazards regression. 
HRs with 95% CI were reported. Linear trends, using the 
exposure categories as a continuous variable were also 
presented. Potential confounders such as age, highest 
education levels achieved, time spent walking (hours/
day), family history of breast cancer, oral contracep-
tive (OC) use, HRT use, parity, age at first birth, age of 
menarche and dietary pattern (meat eaters, fish eaters 
and vegetarians) were included in the fully adjusted 
models. In addition, BMI at 20 years was also adjusted for 
all adipose indicators, except BMI at 20 years. All statis-
tical analyses were conducted using Stata V.14.
results
After excluding the prevalent cases at baseline and inci-
dent cases developed within 1 year of questionnaire 
returned, 17 715 postmenopausal women were included 
in this analysis. From 282 277 person-years follow-up, 
there were 946 incident breast cancer cases with an inci-
dence rate of 3.35 per 1000 women.
The mean (SD) age of the postmenopausal partici-
pants at enrolment was 58.8 (7.5) years. The majority 
were white (99.1%), about one-fifth had tertiary qualifi-
cations, 10% were smokers, 11% self-reported being on 
a vegetarian diet, 3% reported a family history of breast 
cancer, about 41% had ever taken HRT, 52% ever used 
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OC and 17% were nulliparous. The mean (SD) BMI at 
enrolment and at 20 years of age were 24.9 (4.3) kg/
m2 and 21.5 (2.9) kg/m2, respectively (table 1). The 
correlation between skirt size and blouse size was very 
high (r=0.91, p<0.001) while the correlation between 
BMI and waist circumference was only moderate 
(r=0.65, p<0.001). Skirt size was highly correlated with 
waist circumference (r=0.76, p<0.0001) while blouse 
size was highly correlated with BMI (0.78, p<0.0001) 
(online supplementary table 1).
Incidence rates (per 1000 women) for postmenopausal 
breast cancer increased by BMI categories at enrolment, 
BMI categories at 20 years old and weight change (from 
20 years old to enrolment age) (table 2). Obese women at 
recruitment had the highest incidence rates while women 
with the highest weight loss from age 20 had the lowest 
incidence rate of postmenopausal breast cancer.
After adjustment for potential confounders, adipose 
indicators at enrolment namely BMI, waist circumfer-
ence and clothing sizes (blouse and skirt sizes) were 
associated with increased risk for postmenopausal breast 
cancer (table 3). Postmenopausal women who were over-
weight (HR: 1.34, 95% CI: 1.09 to 1.65) or obese (HR: 
1.27, 95% CI: 0.91 to 1.76) had higher risks of breast 
cancer compared with those with normal weight at enrol-
ment. There was no association observed for women in 
the underweight category. No association was observed 
for BMI at 20 years with postmenopausal breast cancer 
risk.
BMI and blouse size (which indicate general obesity), as 
well as waist circumference and skirt size (which indicate 
central obesity), had positive association with postmeno-
pausal breast cancer. There was an increase of 3% in HR 
for every unit increase in BMI and 6% in HR for every 
5 cm increase in waist circumference after adjustment 
for confounders. There was an additional 1% increase in 
HRs for both BMI and waist circumference after addition-
ally adjusted for BMI at 20 years for both BMI and waist 
circumference. For every 2-unit increase in blouse and 
skirt sizes (as UK clothes size increased by 2 units), the 
HRs for blouse and skirt sizes were 1.08 (95% CI: 1.01 to 
1.14) and 1.12 (95% CI: 1.06 to 1.19), respectively. The 
HRs increased to 1.10 (95% CI: 1.03 to 1.18) and 1.14 
(95% CI: 1.06 to 1.22) for blouse and skirt sizes, respec-
tively, after additional adjustment for BMI at 20 years of 
age.
Weight change over adulthood was associated with 
increased risk for postmenopausal breast cancer 
(HR: 1.02, 95% CI: 1.01 to 1.03). For every 1 kg weight 
change, there was a corresponding 2% risk increase after 
adjusting for confounders. Similar results were observed 
when weight change was additionally adjusted for BMI 
at 20 years (table 4). There was an increasing trend in 
associated risks with postmenopausal breast cancer (p for 
trend <0.001) when weight change was categorised into 
groups of weight loss, stable weight and increased weight, 
using stable weight as the reference category.
Table 1 Descriptive characteristics of postmenopausal 
women
Total n (%)
Age (mean±SD) years 17 686 58.8±7.5
Highest education achieved 15 521
  No education 3950 (25.5)
  O-level 4682 (30.2)
  A-level 3700 (23.8)
  Degree 3189 (20.6)
White 17 149 16 995 (99.1)
Food groups 15 602
  Meat eaters 12 175 (78.0)
  Fish eaters 1700 (10.9)
  Vegetarians 1727 (11.1)
Smokers 17 714 1758 (9.9)
Walking (mean±SD) (hours/day) 15 866 0.94±0.77
Family history of  
breast cancer
17 715 539 (3.0)
Ever taken HRT 17 031 7045 (41.4)
Ever used OC 17 362 8997 (51.8)
Parity 17 292
  0 2937 (16.9)
  1–2 8685 (50.2)
  3–4 5129 (29.7)
  ≥5 541 (3.1)
Age of menarche
(mean±SD) (years)
17 247 12.9±1.6
Age of first birth
(mean±SD) (years)
14 336 25.3±4.4
BMI at enrolment
(mean±SD) (kg/m2)
17 029 24.9±4.3
Waist circumference
(mean±SD) (cm)
14 491 75.3±9.7
BMI at 20 years
(mean±SD) (kg/m2)
16 077 21.5±2.9
Weight at 20 years
(mean±SD) (kg)
16 388 57.5±8.3
BMI categories at enrolment 17 029
  Underweight (<18.5 kg/m2) 327 (1.9)
  Normal weight (18.5–24.9 kg/m2) 9816 (57.6)
  Overweight (25.0–29.9 kg/m2) 4936 (29.0)
  Obese (>30.0 kg/m2) 1950 (11. 5)
BMI categories at 20 years old 16 077
  Underweight (<18.5 kg/m2) 1568 (9.8)
  Normal weight (18.5–24.9 kg/m2) 13 128 (81.7)
  Overweight (25.0–29.9 kg/m2) 1176 (7.3)
  Obese (>30.0 kg/m2) 205 (1.3)
Skirt sizes 16 933
  ≤10 1036 (6.1)
  12 3139 (18.5)
  14 4806 (28.4)
  16 4144 (24.5)
  18 2238 (13.2)
  ≥20 1570 (9.3)
Continued
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DIsCussIOn
Our results suggested that clothing size such as blouse and 
skirt sizes can be used as adipose indicators in predicting 
postmenopausal breast cancer. Trouser and skirt sizes 
have been reported to predict cancer risks independent 
of BMI,10 while skirt size changes between 20 years of age, 
and postmenopausal age was reported to be associated 
with postmenopausal breast cancer.11 However, blouse 
size has not been explored as a proxy for general obesity 
in predicting postmenopausal breast cancer. Our study 
confirms and provides additional evidence that skirt size is 
associated with the risk of postmenopausal breast cancer. 
In addition, our study may be the first to provide evidence 
that larger blouse size is associated with increased risk 
of postmenopausal breast cancer. The clothing sizes 
will provide additional indicators as proxy for adiposity 
if patients fail to recall (especially the elderly) or feel 
embarrassed to disclose their weight or BMI (for those 
who are obese).
Skirt size and waist circumference were highly correlated 
and performed equally well in predicting postmenopausal 
breast cancer risk. Our findings provide additional evidence 
of using skirt size as a proxy for central obesity in predicting 
postmenopausal breast cancer. On the other hand, there was 
no previous report on blouse size associated with increased 
risk of postmenopausal breast cancer. Blouse size could 
serve as an indicator for general obesity as it has a strong 
correlation with BMI. Blouse size also performed as well as 
BMI in predicting breast cancer among postmenopausal 
women. A previous study conducted in the UK reported 
that among 362 respondents, only 3% reported a clothing 
size different from their clothing labels.9 This indicated that 
self-reported clothing size is reliable. Blouse and skirt sizes 
which are simple and non-invasive self-reported measures 
could be promoted as proxies for adipose indicators. From 
a public health perspective, these findings are significant 
when anthropometric measurements are not available, or 
challenging in their measurements due to extreme obesity.10
Overweight and obese women at enrolment had up to 
32% increased risk of postmenopausal breast cancer. The 
association between overweight/obesity with postmeno-
pausal breast cancer remained after further adjustment for 
BMI at 20 years. Women who gained the most weight since 
the age of 20 years old, had almost 30% increased risk of 
postmenopausal breast cancer after adjustment for potential 
confounders and BMI at 20 years. Similar findings have been 
reported by other researchers.16–19
Different periods of weight gain (ie, between age 18 
years and the current age, between ages 18 and 35 years, 
between ages 35 and 50 years and between age 50 years and 
the current age) were consistently associated with increased 
breast cancer risk.20 Similar findings were reported by 
Eliassen et al21 that women who gained weight since age 18 
years or since menopause were at an increased risk of breast 
cancer. These results suggest that regardless of BMI in early 
adulthood, being obese in later life or gaining weight along 
the way increases deposition of adipose tissue. After meno-
pause, adipose tissue is the major location for the synthesis of 
oestrogens. Circulating oestrogen are higher in obese than 
in slim postmenopausal women.19 Obesity also contributes 
to inflammatory changes leading to macrophage polarisa-
tion and altered adipokine profile.22 These mechanisms may 
explain the association which links obesity and postmeno-
pausal breast cancer together.
Consistent with previous literature6 11 23; waist circum-
ference as an indicator for central obesity was found to be 
positively associated with postmenopausal breast cancer. 
Total n (%)
Blouse sizes 16 248
  ≤10 1338 (8.2)
  12 3668 (22.6)
  14 4637 (28.5)
  16 3544 (21.8)
  18 1726 (10.6)
  ≥20 1335 (8.2)
BMI, body mass index; HRT, hormone replacement therapy; OC, oral 
contraceptive. 
Table 1 Continued 
Table 2 Incidence rates of postmenopausal breast cancer 
by body mass index (BMI) groups and groups of weight 
change
n
Person-
years Cases
Incidence 
rate
(per 1000)
BMI groups at enrolment
  Underweight 327 5051 8 1.58
  Normal weight 9813 1 58 418 475 2.99
  Overweight 4936 77 987 300 3.85
  Obese 1950 30 177 120 3.98
  Total 17 026 271 634 903 3.32
BMI groups at 20 years
  Underweight 1568 25 006 78 3.11
  Normal weight 13 125 209 950 717 3.42
  Overweight 1176 18 712 53 2.83
  Obese 205 3165 10 3.16
  Total 16 074 256 834 858 3.34
Weight change
  Weight loss ≥5 kg 988 15 536 27 1.74
  Weight loss 
2–4.9 kg
745 12 116 25 2.06
  Stable weight 
(±1.9 kg)
1820 29 436 87 2.96
  Weight gain 
2–9.9 kg
6287 101 530 336 3.31
  Weight gain 10–
19.9 kg
4450 70 498 264 3.74
  Weight gain ≥20 kg 1969 30 632 125 4.08
  Total 16 259 259 752 864 3.33
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The association remained after adjustment for potential 
confounders and BMI at 20 years. This may indicate that 
regardless of being obese in early adulthood or at later 
life, being centrally obese in later life increases the risk of 
postmenopausal breast cancers. Central obesity is associ-
ated with increased insulin levels and insulin-like growth 
Table 3 Crude and adjusted HR of general and central adiposity indicators
Age-adjusted HR (95% CI) Model 1 HR (95% CI) Model 2 HR (95% CI)
BMI groups at 20 years 
  Cases/total 857/16 055 457/8825 NA
   Underweight 0.93 (0.73 to 1.15) 0.97 (0.71 to 1.34) – 
   Normal weight 1.00 1.00
   Overweight 0.83 (0.63 to 1.01) 0.81 (0.55 to 1.21) – 
   Obese 0.94 (0.51 to 1.76) 0.42 (0.10 to 1.68) – 
   Linear model (per kg/m2) 0.98  (0.96   to 1.00) 0.98 (0.94 to 1.01) – 
   P for trend (linear model) 0.123 0.168 – 
BMI groups at enrolment
  Cases/total 901/17 003 476/9241 453/8781
   Underweight 0.54 (0.27 to 1.09) 0.49 (0.16 to 1.55) 0.32 (0.08 to 1.30)
   Normal weight 1.00 1.00 1.00
   Overweight 1.27 (1.10 to  1.47) 1.28 (1.05 to 1.56) 1.34 (1.09 to 1.65)
   Obese 1.32 (1.08 to  1.62) 1.18 (0.88 to 1.59) 1.27 (0.91 to 1.76)
   Linear model (per kg/m2) 1.03 (1.02 to 1.04) 1.03 (1.00 to 1.05) 1.04 (1.02 to 1.07)
   P for trend (linear model) 0.021 0.001
Waist circumference at enrolment
  Case/total 776/14 476 483/9334 380/7377
   Waist circumference (per 5 cm) 1.05 (1.02 to 1.09) 1.06 (1.01 to 1.11) 1.07 (1.01 to 1.14)
Skirt size at enrolment
  Case/total 911/16 906 479/9197 447/8552
   ≤10 1.00 1.00 1.00
   12 1.95 (1.29 to 2.96) 2.06 (1.12 to 3.78) 1.92 (1.04 to 3.54)
   14 2.02 (1.34 to 3.03) 2.43 (1.35 to 4.39) 2.45 (1.35 to 4.43)
   16 2.31 (1.54 to 3.48) 2.74 (1.51 to 4.97) 2.87 (1.58 to 5.22)
   18 2.32 (1.52 to 3.55) 2.67 (1.43 to 4.98) 2.74 (1.45.5.15)
   ≥20 2.57 (1.66 to 3.97) 3.21 (1.70 to 6.08) 3.06 (1.58 to 5.93)
   Linear model (per 2 unit)  1.09 (1.05 to 1.15) 1.12 (1.06 to 1.19) 1.14 (1.06 to 1.22)
   P for trend (linear model) <0.001 <0.001 <0.001
Blouse size at enrolment
Case/total 873/16 222 459/8834 428/8206
   ≤10 1.00 1.00 1.00
   12 1.56 (1.13 to 2.17) 2.04 (1.24 to 3.36) 2.11 (1.26 to 3.53)
   14 1.59 (1.16 to 2.20) 2.13 (1.30 to 3.48) 2.25 (1.36 to 3.75)
   16 1.74 (1.25 to 2.42) 2.20 (1.33 to 3.64) 2.39 (1.42 to 4.03)
   18 1.57 (1.09 to 2.26) 2.02 (1.16 to 3.52) 2.21 (1.24 to 3.96)
   ≥20 2.11 (1.46 to 3.03) 2.63 (1.50 to 4.61) 2.92 (1.60 to 5.32)
   Linear model (per 2 unit) 1.08 (1.03 to 1.12) 1.08 (1.01 to 1.14) 1.10 (1.03 to 1.18)
   P for trend (linear model) 0.001 0.019 0.005
Model 1: adjusted for age, education levels, parity, age at first birth, age of menarche, use of HRT, use of OC, family history of breast cancer, 
dietary pattern, walking (hours/day).
Model 2: model 1+BMI at 20 years.
BMI, body mass index; HRT, hormone replacement therapy; OC, oral contraceptive. 
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factors which may stimulate the growth of breast cancer 
cells and neoplastic degeneration.24
According to the latest report (2017) from the World 
Cancer Research Fund International/American Institute 
for Cancer Research, being overweight or obese during 
young adulthood decreases the risk of postmenopausal 
breast cancer.6 Low levels of adiposity in the mammary 
gland may alter breast tissue maturation, making breast 
tissue more susceptible to carcinogenic stimuli among 
leaner women. Sex hormone levels may also explain 
the inverse relationship between early life adiposity and 
breast cancer risk. However, we did not find BMI at 20 
years to be negatively associated with postmenopausal 
breast cancer incidence, as also reported by other cohort 
studies.16 25
There are a few limitations which need to be consid-
ered while interpreting the results. All adipose indicators, 
blouse and skirt sizes were self-reported. Some overweight 
or obese women may be more likely to under-report their 
weight compared with normal-weight participants. On 
the other hand, blouse and skirt sizes offer an objective 
standard as a proxy to report overweight/obesity which 
are potentially less liable for misreporting. We were 
unable to evaluate in more detail the effect of weight gain 
at different ages, other than that of weight at age 20 years 
and weight at enrolment. Breast tumour characteristics 
were not available, and we could not explore whether 
our findings may differ by breast cancer subtypes. On 
the other hand, we believe we are the first to report that 
both blouse and skirt sizes predict postmenopausal breast 
cancer risk equally as well as other more invasive measures 
of body size. In addition, our study sample is large with 
long follow-up duration. The linkage of participants’ 
ID with the National Statistics National Health Service 
central register provides accurate information on breast 
cancer diagnosis.
COnClusIOn
Overweight/obesity (BMI and blouse size), central 
obesity (waist circumference and skirt size) and weight 
change during adulthood are associated with increased 
risk of postmenopausal breast cancer. Clothing size such 
as skirt and blouse sizes can be used as a proxy for adipose 
indicators in predicting postmenopausal breast cancer. 
Clothing sizes offer an objective standard as a proxy to 
report overweight/obesity which are useful in the public 
health setting. Maintaining healthy body weight over 
adulthood is an effective measure in the prevention of 
postmenopausal breast cancer.
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